AsymBio is thrilled to join the 3rd ADC Process Development Summit in Boston—our first time at this industry-leading gathering focused on advancing antibody-drug conjugate (ADC) process innovation.Not only are we attending-we are proud to serve as a sponsor, too! This event is all about bringing together ADC and bioconjugate experts, and we can’t wait to connect with both new industry peers and longstanding partners who share our drive to elevate biotherapeutic development.Stop by to chat with our team and learn more about our end-to-end integrated solutions for bioconjugates (including ADCs)—from pre-clinical development and clinical advancement all the way to commercialization. Whether you’re tackling process challenges or exploring scalable pathways for your program, we’re here to share insights and support your goals.

See you in Boston!